Imagine saving millions of lives and then discovering that your greatest achievement has divided your own country. After decades of quiet research, you become your country's first Nobel Prize winner in science, only to return home and find that not everyone believes the award belongs to you alone.
This is the story of Chinese pharmacologist Tu Youyou, whose discovery of artemisinin, one of the world's most effective malaria treatments, transformed global healthcare. Her achievement earned her the 2015 Nobel Prize in Physiology or Medicine, making her the first Chinese-trained scientist to receive a Nobel in a scientific field.
Yet her Nobel Prize became more than recognition for a life-saving discovery. It sparked a national debate about teamwork, scientific recognition, and whether groundbreaking discoveries belong to one brilliant individual or to the hundreds of people who helped make them possible. More than a decade later, Tu Youyou's story continues to raise an important question: who truly deserves credit for changing the world?
A Secret Mission During Wartime
In the late 1960s, the Vietnam War was claiming thousands of lives. Ironically, more soldiers were dying from malaria than from bullets or bombs, a disease spread by mosquitoes. Existing medicines were becoming less effective as the malaria parasite developed resistance, creating an urgent need for a new treatment.
Responding to requests for help from North Vietnam, Chinese leader Mao Zedong approved a secret military research programme in 1967 known as Project 523, named after its launch date of 23 May.
The project brought together more than 500 scientists from around 60 research institutes across China. Botanists, chemists, pharmacologists, physicians and military researchers worked together under strict secrecy. Because of its military importance, their findings could not be openly published, and individual researchers rarely received public recognition.
Among the many scientists assigned to the project was Tu Youyou, a pharmacologist working at the China Academy of Traditional Chinese Medicine. At the time, few could have predicted that her work would eventually reshape global medicine.
Ancient Knowledge Meets Modern Science
Unlike many internationally recognised scientists, Tu Youyou did not have a PhD or a medical degree. She had never studied abroad and was not considered part of China's scientific elite. Instead, she relied on something often overlooked in modern laboratories: ancient medical knowledge.
Her team began reviewing thousands of traditional Chinese remedies in search of possible malaria treatments. During this search, Tu discovered a passage in a medical text written nearly 1,700 years ago by physician Ge Hong. The text described using sweet wormwood (Artemisia annua) to treat recurring fevers, a common symptom of malaria. The discovery showed that innovation sometimes begins by revisiting old knowledge with new methods.
Earlier experiments with sweet wormwood had produced inconsistent results because researchers boiled the plant during extraction. Tu carefully reread the ancient instructions and noticed that the herb was meant to be soaked and squeezed rather than heated. This led her to believe that high temperatures were destroying the active ingredient.
Her team redesigned the extraction process using a low-temperature method. The new extract proved remarkably effective against the malaria parasite.
Before asking anyone else to take the medicine, Tu and her colleagues tested it on themselves to ensure it was safe. It was a risky decision by today's ethical standards, but it reflected the urgency of the crisis and their confidence in the research.
The active compound they isolated became known as artemisinin, a discovery that would eventually transform malaria treatment around the world.
A Discovery that Changed Global Health
The impact of artemisinin extended far beyond the laboratories where it was discovered. As further research confirmed its effectiveness, artemisinin-based medicines became the foundation of Artemisinin-based Combination Therapies (ACTs), now recommended by the World Health Organisation (WHO) as the standard treatment for malaria.
Over the following decades, these treatments dramatically reduced malaria deaths, particularly in Africa and parts of Asia where the disease had long been a major public health challenge. Millions of lives have been saved because of therapies built around Tu Youyou's discovery.
In recognition of this achievement, Tu was awarded the 2015 Nobel Prize in Physiology or Medicine, sharing the honour with William C. Campbell and Satoshi Ōmura for their work on treatments against parasitic diseases.
For China, the award represented a historic milestone. Tu became the first Chinese-trained scientist to receive a Nobel Prize in a scientific category, proving that groundbreaking discoveries could emerge from research conducted entirely within the country. The Nobel Prize seemed like the perfect ending to the story. Yet the story was far from over.
Why China Celebrated Tu Youyou
Tu Youyou's Nobel Prize was widely celebrated across China. For decades, the country had hoped to see one of its own scientists recognised with the world's most prestigious scientific award. Her victory became a source of national pride.
Chinese media celebrated Tu's achievement as proof that scientific excellence could emerge from within the country. Government leaders also praised her work, describing it as a milestone for Chinese science and a source of national pride. For many young researchers, her success became an inspiring reminder that groundbreaking discoveries do not always require elite credentials.
The discovery also highlighted the value of Traditional Chinese Medicine (TCM). While artemisinin became a modern pharmaceutical through rigorous scientific testing, its original inspiration came from ancient Chinese medical literature. Many people viewed this as evidence that traditional knowledge, when examined through modern scientific methods, could make meaningful contributions to global healthcare.
Tu herself also became a symbol of perseverance. She had achieved international recognition without a doctoral degree, overseas education or membership in China's most prestigious scientific academies. Her success challenged the belief that only elite credentials produce world-changing discoveries.
For many Chinese citizens, her Nobel Prize represented not only personal achievement but also recognition of China's contribution to improving global health.
Why China also Resented the Nobel
Despite widespread celebration, the Nobel Prize also sparked an unexpected controversy within China.
The main criticism was not directed at Tu herself, but at the way the Nobel Prize recognises scientific discoveries.
Project 523 had never been a one-person project. It involved more than 500 researchers, working across dozens of institutes over many years. Chemists isolated compounds, botanists studied medicinal plants, clinicians tested treatments, and countless researchers contributed experiments that never appeared in history books.
Because the project was classified as a military secret, many early publications listed only the name of the research group rather than individual authors. Within China's scientific culture, this reflected an important principle: major discoveries were viewed as collective achievements rather than personal victories.
Many scientists therefore argued that recognising Tu alone overlooked the enormous contribution of the wider research team. From this perspective, artemisinin was not the achievement of one individual but the result of years of collaboration involving hundreds of people. But if hundreds of people contributed, how should history decide whose name is remembered?
This debate also reflected broader cultural differences.
Western scientific traditions often celebrate individuals. History remembers names like Isaac Newton, Marie Curie, Alexander Fleming and Albert Einstein. Nobel Prizes are awarded to people, not institutions.
In contrast, China's research culture has historically placed greater emphasis on teamwork, collective effort and national achievement. Scientific success is often viewed as something built by many hands rather than a single genius.
Interestingly, Tu herself rarely claimed sole credit. She repeatedly acknowledged the importance of her colleagues and described the Nobel Prize as an honour shared with her team and with China.
The controversy therefore was not about whether Tu deserved recognition. Rather, it questioned whether one award could ever fully represent a discovery made through such an enormous collaborative effort.
A Question Bigger than One Nobel Prize
The debate surrounding Tu Youyou reaches far beyond China or the Nobel Prize.
Modern scientific breakthroughs are rarely created by one person working alone. Behind every major discovery are laboratory assistants, technicians, researchers whose experiments failed, supervisors who secured funding, and teams who refined ideas over many years.
At the same time, history often remembers individuals because people connect more easily with stories than with institutions. Perhaps that is why history remembers names, while science remembers teams. A single name gives the public someone to celebrate, even when the reality is far more complex.
Perhaps both perspectives hold some truth. Individual insight matters. Tu's decision to revisit an ancient medical text and rethink the extraction process was a crucial turning point. Yet without Project 523, the support of hundreds of researchers and years of collaborative work, that insight might never have become a medicine that reached patients around the world.
The challenge lies in recognising both exceptional leadership and collective effort without diminishing either.
Tu Youyou's discovery of artemisinin changed the course of global medicine. Millions of people are alive today because researchers refused to give up on finding a better treatment for malaria. Her Nobel Prize rightly recognised a remarkable scientific contribution, but it also exposed a question that remains relevant in every field of research.
Scientific breakthroughs are rarely the work of one mind alone. They emerge from curiosity, persistence, collaboration and the willingness to challenge accepted ideas. Science may begin with one brilliant insight, but progress is almost always built by many hands. Tu Youyou's story reminds us that while awards often recognise individuals, the greatest discoveries are rarely achieved alone.
Perhaps that is why Tu Youyou's story continues to resonate. It is not only the story of a life-saving medicine or a Nobel Prize, but it is also a reminder that the path to discovery is often shared, even when recognition is not. "Perhaps that is the true legacy of Tu Youyou's story, not simply that one woman changed medicine, but that history often remembers one name while science advances through the efforts of many."
"The Nobel Prize is an honour for all Chinese Scientists"
-Tu Youyou
References:
- Nobel Prize Outreach AB. (2015). The Nobel Prize in Physiology or Medicine 2015.
https://www.nobelprize.org - Nobel Prize Outreach AB. Tu Youyou – Facts. https://www.nobelprize.org
- Nobel Prize Outreach AB. Tu Youyou – Nobel Lecture: Discovery of Artemisinin – A Gift from Traditional Chinese Medicine to the World.
https://www.nobelprize.org - Huang, Y. (2015). Tu Youyou: An Outlier of China's Scientific and Technological System. Council on Foreign Relations. https://www.cfr.org
- IBSA Foundation. (2020). Tu Youyou, the Nobel Prize for Her Work on Malaria.
https://www.ibsafoundation.org - Biological Magnetic Resonance Bank. Artemisinin – Molecular Highlights.
https://bmrb.io - Fallows, J. (2015). The Significance of a Nobel Prize for a Chinese Scientist. The Atlantic.
https://www.theatlantic.com - Zhang Yan. (2015). All China Wanted Was a Nobel Prize: So Why Is It So Unexcited About the Chinese Scientist Who Finally Won One? Slate (adapted from Caixin).
https://slate.com - World Health Organisation. Malaria.
https://www.who.int - Zheng, W., Li, E., Peng, S., & Wang, X. (2020). Tu Youyou Winning the Nobel Prize: Ethical Research on the Value and Safety of Traditional Chinese Medicine. Bioethics, 34(2), 166–171. https://pmc.ncbi.nlm.nih.gov
. . .